Simultaneous Primary Bilateral Orbital Invasive Aspergillosis: A Rare Presentation
Citation Information :
Simultaneous Primary Bilateral Orbital Invasive Aspergillosis: A Rare Presentation. Clin Rhinol An Int J 2011; 4 (3):168-170.
Copyright © 2011; The Author(s).
The occurrence of invasive orbital aspergillosis in an immunocompetent individual is rare. To our knowledge, primarily bilateral invasive orbital aspergillosis has not been reported in the English literature. We are reporting this case of primary bilateral invasive orbital aspergillosis, which posed a great dilemma regarding its ideal management, to initiate a discussion and get a feedback regarding the ideal management protocol in such a situation.
The spectrum of orbital aspergillosis: A clinicopathological review. Surv Ophthalmol 1996;41:142-54.
Sino-orbital and cerebral aspergillosis: Cure with medical therapy. Mykosen 1987;30:379-85.
Aspergillosis of the orbit. Arch Ophthalmol 1969;82:302-13.
Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin B and surgery. JAMA 1980; 244:814-15.
Amphotericin B refractory aspergillosis after itraconazole: Evidence for significant antagonism. Mycoses 1993;36:421-24.
In vitro susceptibility and synergy studies of aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992;15:21-34.
Aspergillus species. In: Mandell GL, Bennett JE, Dolin R (Eds). Principles and practice of infectious diseases. (5th ed). Philadelphia: Churchill Livingstone 2000;2:2674-85.
Orbital aspergillosis a fatal masquerader. J Neuroophthalmol 1997;17:257-61.
Itraconazole in the treatment of orbital aspergillosis. Ophthalmology 1996;103: 1467-70.
Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal amphotericin B and itraconazole. Ann Otol Rhinol Laryngol 1999;108:205-07.
Host defense mechanisms in aspergillus fumigatus infections. Contrib Microbiol 1999;2: 57-68.
Treatment of invasive aspergillus sinusitis with liposomal-amphotericin B. Laryngoscope 1987; 97:937-41.
Practice guidelines for disease caused by aspergillus. Clin Infect Dis 2000;30:696-709.
Itraconazole resistance in aspergillus fumigatus. Antimicrob Agents Chemother 1997;41:1364-68.
Should voriconazole be the primary therapy for chronic invasive sinus aspergillosis? Clinical Rhinology-An International Journal 2011;4(1):21-26.
New investigational triazole agents for the treatment of invasive fungal infections. J Chemother 2008;20:661-71.